0

Generic Oncology Drugs Market Insights, Trends, Opportunity & Forecast

Generic Oncology Drugs Market By Molecule Type (Small Molecule and Large Molecule), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) – Global Market Size, Development, Growth and Demand Forecast, 2018-2027

Category: Healthcare | Report ID: FAMR-00101 | Published on: Nov 2019 | Share:         

Select License Type
  • Single User License $3555 USD
  • Multi-User License $4365 USD
  • Corporate User License $4905 USD
  • Report Description
  • Table Of Content
  • Request Methodology

Increasing incidence of cancer which may occur due to the many factors like smoking and tobacco consumption, change in a sedentary lifestyle, genetic causes, viral infections, carcinogens, and high consumption of junk food, is expected to boost the revenue of generic oncology drugs market. For instance, According to the American Cancer Society, Inc. estimates, there are 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.

Dozens of generic oncology drugs launched per year by various pharma companies, as the patents that protect exclusive marketing rights on the novel oncology drugs get expire or are circumvented. This provides lucrative opportunities for these manufacturers to obtain significant market share in the generic oncology drugs market. For instance, on July 2019, Lupin Limited launched the generic Imatinib Mesylate tablets in different strengths (100 mg and 400 mg) in U.S. Imatinib Mesylate tablets are the generic form of Novartis AG’s Gleevec tablets in the same strengths and used for treatment of certain types of cancer including newly diagnosed adult and pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase and for adult patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia. However, the shortage of various generic oncology drugs posing a challenge for patients, seeking treatment. Bleomycin, carboplatin, carmustine, cisplatin, fluorouracil, gemcitabine, irinotecan, methotrexate, mitomycin and etoposide are some of the drugs which have a shortage in the market. Thus, the government and pharmaceutical companies are taking various initiatives to address drug shortages. For instance, in May 2019, ProvideGx, LLC, a consolidated subsidiary of Premier Inc. entered into a partnership agreement with Fresenius Kabi to help mitigate national shortages of injectable thiamine, hydromorphone, lidocaine, morphine sulfate, and diphenhydramine. The supply of these products by Fresenius Kabi and ProvideGx, LLC, will be available for purchase by any health system or healthcare provider at competitive prices. Thus, such an initiative will drive the growth of critical care drugs to be used in hospitals and clinics to treat patients with critical and chronic conditions at a faster pace.

Get a brochure of this research study Click Here

Generic Oncology Drugs Market Regional Analysis 

On the basis of region, North America is expected to show a leading position in the generic oncology drugs market followed by Europe. This is attributed to growing initiatives by the government to cut down the prices on drugs. For instance, Trump Administration has proposed a plan to reduce drug prices in the U.S. in order to reduce the burden on Americans with higher insurance premiums, high out-of-pocket costs, high deductibles, and high copay prescription expenses. 

The Asia Pacific also contribute noteworthy growth in generic oncology drugs market attributed to increasing initiatives by pharmaceutical manufacturers to develop and process new generic drugs as per the quality norms set by the respective country’s authority. For instance, Pune-based Emcure Pharma introduced Eribulin in India, for the treatment of Breast Cancer. Eribulin is the generic version of Eisai Pharma’s Halaven (Eribulin) and Emcure Pharma sells the Eribulin at the price 40% less than the originator’s drug. The launch of this drug help to overcome the high-cost treatment challenge that most patients are facing and create competitive rivalry among other pharma companies to operate. 

Moreover, the Middle East also provides significant growth in the market due to the increasing inclination of the population towards the consumption of cigarettes and alcohol, which may lead to lung cancers. For instance, According to the World Health Organization (WHO), Middle East is one of the regions in the world where cigarette consumption increased in the past few decades and around 30,000 people will be diagnosed with lung cancer in the Middle East by 2020.

Key players operating in the generic oncology drugs markets include Teva Pharmaceuticals Industries Ltd., Mylan N.V., Pfizer, Inc., Novartis AG, Merck & Co., Inc., AbbVie Inc., and Sanofi S.A., Aurobindo, AstraZeneca Plc, Eli Lily and Company, Johnson and Johnson, Hoffmann-La Roche, CELGENE Corporation, GlaxoSmithKline, Dr. Reddy’s Laboratories, Glenmark, Greenstone, Lannett Company, Lupin Limited, Par Pharma, Taro, Upsher-Smith Laboratories, Wockhardt, and Zydus and others

Generic Oncology Drugs Market-Taxonomy

By Molecule Type

-Small Molecule
-Large Molecule

By Route of Administration

-Oral
-Parenteral

By Distribution Channel

-Hospital Pharmacies
-Retail Pharmacies
-Online Pharmacies

By Region

-North America
-Europe
-Asia Pacific
-Latin America
-The Middle East and Africa 

Research Methodology

Market Definition and List of Abbreviations

1. Executive Summary
2. Growth Drivers & Issues in Global Generic Oncology Drugs Market
2.1. North America
2.2. Europe
2.3. Asia Pacific
2.4. Europe
2.5. Middle East & Africa

3. Global Generic Oncology Drugs Market Trends
4. Opportunities in Global Generic Oncology Drugs Market
5. Recent Industry Activities, 2018
6. Porter's Five Forces Analysis
7. Macro-Economic Trends
8. PEST Analysis
9. Market Value Chain and Supply Chain Analysis
10. Global Generic Oncology Drugs Market Value (USD Million), 2018-2024

11. Global Generic Oncology Drugs Market Segmentation Analysis, By Molecule Type
11.1. Introduction
11.2. Market Attractiveness, By Molecule Type
11.3. BPS Analysis, By Molecule Type
11.4. Small Molecule Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
11.5. Large Molecule Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

12. Global Generic Oncology Drugs Market Segmentation Analysis, By Route of Administration
12.1. Introduction
12.2. Market Attractiveness, By Route of Administration
12.3. BPS Analysis, By Route of Administration
12.4. Oral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
12.5. Parenteral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

13. Global Generic Oncology Drugs Market Segmentation Analysis, By Distribution Channel
13.1. Introduction
13.2. Market Attractiveness, By Distribution Channel
13.3. BPS Analysis, By Distribution Channel
13.4. Hospital Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
13.5. Retail Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
13.6. Online Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14. Geographical Analysis
14.1. Introduction

14.2. North America Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.1. By Molecule Type
14.2.1.1. Introduction
14.2.1.2. Market Attractiveness, By Molecule Type
14.2.1.3. BPS Analysis, By Molecule Type
14.2.1.4. Small Molecule Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.1.5. Large Molecule Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.2. By Route of Administration
14.2.2.1. Introduction
14.2.2.2. Market Attractiveness, By Route of Administration
14.2.2.3. BPS Analysis, By Route of Administration
14.2.2.4. Oral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.2.5. Parenteral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.3. By Distribution Channel
14.2.3.1. Introduction
14.2.3.2. Market Attractiveness, By Distribution Channel
14.2.3.3. BPS Analysis, By Distribution Channel
14.2.3.4. Hospital Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.3.5. Retail Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.3.6. Online Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.4. By Country
14.2.4.1. Market Attractiveness, By Country
14.2.4.2. BPS Analysis, By Country
14.2.4.3. U.S. Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.2.4.4. Canada Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.3. Europe Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.1. By Molecule Type
14.3.1.1. Introduction
14.3.1.2. Market Attractiveness, By Molecule Type
14.3.1.3. BPS Analysis, By Molecule Type
14.3.1.4. Small Molecule Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.1.5. Large Molecule Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.2. By Route of Administration
14.3.2.1. Introduction
14.3.2.2. Market Attractiveness, By Route of Administration
14.3.2.3. BPS Analysis, By Route of Administration
14.3.2.4. Oral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.2.5. Parenteral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.3. By Distribution Channel
14.3.3.1. Introduction
14.3.3.2. Market Attractiveness, By Distribution Channel
14.3.3.3. BPS Analysis, By Distribution Channel
14.3.3.4. Hospital Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.3.5. Retail Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.3.6. Online Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.4. By Country
14.3.4.1. Market Attractiveness, By Country
14.3.4.2. BPS Analysis, By Country
14.3.4.3. Germany Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.4.4. United Kingdom Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.4.5. France Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.4.6. Italy Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.4.7. Spain Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.4.8. Russia Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.3.4.9. Rest of Europe Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.4. Asia Pacific Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.1. By Molecule Type
14.4.1.1. Introduction
14.4.1.2. Market Attractiveness, By Molecule Type
14.4.1.3. BPS Analysis, By Molecule Type
14.4.1.4. Small Molecule Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.1.5. Large Molecule Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.2. By Route of Administration
14.4.2.1. Introduction
14.4.2.2. Market Attractiveness, By Route of Administration
14.4.2.3. BPS Analysis, By Route of Administration
14.4.2.4. Oral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.2.5. Parenteral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.3. By Distribution Channel
14.4.3.1. Introduction
14.4.3.2. Market Attractiveness, By Distribution Channel
14.4.3.3. BPS Analysis, By Distribution Channel
14.4.3.4. Hospital Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.3.5. Retail Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.3.6. Online Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4. By Country
14.4.4.1. Market Attractiveness, By Country
14.4.4.2. BPS Analysis, By Country
14.4.4.3. China Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.4. India Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.5. Japan Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.6. South Korea Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.7. Indonesia Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.8. Taiwan Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.9. Australia Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.10. New Zealand Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.4.4.11. Rest of Asia Pacific Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.5. Latin America Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.1. By Molecule Type
14.5.1.1. Introduction
14.5.1.2. Market Attractiveness, By Molecule Type
14.5.1.3. BPS Analysis, By Molecule Type
14.5.1.4. Small Molecule Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.1.5. Large Molecule Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.2. By Route of Administration
14.5.2.1. Introduction
14.5.2.2. Market Attractiveness, By Route of Administration
14.5.2.3. BPS Analysis, By Route of Administration
14.5.2.4. Oral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.2.5. Parenteral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.3. By Distribution Channel
14.5.3.1. Introduction
14.5.3.2. Market Attractiveness, By Distribution Channel
14.5.3.3. BPS Analysis, By Distribution Channel
14.5.3.4. Hospital Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.3.5. Retail Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.3.6. Online Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.4. By Country
14.5.4.1. Market Attractiveness, By Country
14.5.4.2. BPS Analysis, By Country
14.5.4.3. Brazil Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.4.4. Mexico Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.5.4.5. Rest of Latin America Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

14.6. Middle East & Africa Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.1. By Molecule Type
14.6.1.1. Introduction
14.6.1.2. Market Attractiveness, By Molecule Type
14.6.1.3. BPS Analysis, By Molecule Type
14.6.1.4. Small Molecule Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.1.5. Large Molecule Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.2. By Route of Administration
14.6.2.1. Introduction
14.6.2.2. Market Attractiveness, By Route of Administration
14.6.2.3. BPS Analysis, By Route of Administration
14.6.2.4. Oral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.2.5. Parenteral Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.3. By Distribution Channel
14.6.3.1. Introduction
14.6.3.2. Market Attractiveness, By Distribution Channel
14.6.3.3. BPS Analysis, By Distribution Channel
14.6.3.4. Hospital Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.3.5. Retail Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.3.6. Online Pharmacies Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.4. By Geography
14.6.4.1. Market Attractiveness, By Geography
14.6.4.2. BPS Analysis, By Geography
14.6.4.3. GCC Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.4.4. North Africa Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.4.5. South Africa Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024
14.6.4.6. Rest of Middle East & Africa Market Value (USD Million) Forecast & Y-o-Y Growth Analysis (%), Market Share (%) 2018-2024

15. Competitive Landscape
15.1. Market Share of Key Players
15.2. Market Positioning of Major Players in Global Generic Oncology Drugs Market
15.3. Company Profiles
15.3.1. Teva Pharmaceuticals Industries Ltd.
15.3.1.1. Company Overview
15.3.1.2. Product Offered
15.3.1.3. Business Strategy
15.3.1.4. Financials
15.3.1.5. SWOT Analysis
15.3.1.6. Market Share Analysis
15.3.1.7. Key Achievements & Developments
15.3.2. Mylan N.V.
15.3.3. Pfizer, Inc.
15.3.4. Novartis AG
15.3.5. Merck & Co., Inc.
15.3.6. AbbVie Inc.
15.3.7. Sanofi S.A.
15.3.8. Aurobindo
15.3.9. AstraZeneca Plc
15.3.10. Eli Lily and Company
15.3.11. Johnson and Johnson
15.3.12. HoffmannLa Roche
15.3.13. CELGENE Corporation
15.3.14. GlaxoSmithKline
15.3.15. Dr. Reddy’s Laboratories
15.3.16. Glenmark
15.3.17. Greenstone
15.3.18. Lannett Company
15.3.19. Lupin Limited
15.3.20. Par Pharma
15.3.21. Taro
15.3.22. UpsherSmith Laboratories
15.3.23. Wockhardt
15.3.24. Zydus
15.3.25. Other Major & Niche Players

16. Disclaimer

Request For Customization



Request Customization

Check Discount



Request Discount
  • Sanofi
  • KOKUYO CO., LTD.
  • 3M Company
  • Danaher Corporation
  • Sekisui Chemical
  • The HC Companies
  • Office Depot
  • The Saudi Arabian Amiantit Company
  • Parade Technologies, Ltd.
  • FKB Válvulas e Comportas
  • Sunon
  • Sou Inc
  • McKinsey & Company
  • Deloitte
  • CQMS Razer
  • Dupont